
    
      The investigators are looking for men or women aged 18 years or older with hepatocellular
      carcinoma not suitable for surgical resection or hepatic transplantation. Prior locoregional
      therapy including but not limited to transarterial chemoembolization (TACE), radiofrequency
      ablation (RFA) or ethanol injection is allowed as long as the treatment was 4 weeks previous.
      Patients must be Child-Pugh A with no previous treatment with sorafenib or other vascular
      endothelial growth factor (VEGF) inhibitors.
    
  